Abstract
The purpose of the present review is to examine the effect of the acute administration (20 mg/ Kg, i.p.) of the 3,4 methylenedioxymethamphetamine (MDMA) in different cerebral areas of rats to better understand the mechanism underlying the toxicity induced by cellular oxidative stress. For this purpose the biochemical parameters of the antioxidant non-enzymatic cellular defense system have been studied (the reduced Glutathione (GSH), the Glutathione Disulfide (GSSG), the Ascorbic Acid (AA) and malondialdehyde (MDA) which indicates perioxidative damage) in the hippocampus, striate, frontal cortex both in treated animals and in control groups to realize a qualitative-quantitative evaluation of the possible alterations of the neuronal redox state induced by the administration of Ecstasy. The administration of MDMA induced the following variations of the antioxidant non enzymatic defense system: 1. the levels of the AA in the treated animals compared with the control group were increased in the striate, hippocampus and in the frontal cortex both at 3h and 6h. 2. In the striate, also MDA was significantly increased both after 3 h and 6 h, while in the hippocampus and in the frontal cortex the MDA was significantly increased after 6 h. 3. An increase of GSH was also observed after 3 h and 6 h in the hippocampus and in the striate while no significative variation were observed in the frontal cortex of the treated rats. 4. An increase of GSSG was significative in the hippocampus and striate at 3h, while at 6h it was significative only in the striate. In conclusion the results of our study seem to confirm the role of the oxidative stress in the mechanism of neuronal toxicity induced by the ecstasy and leads us to hypothesize a possible role of the antioxidant substances in the therapeutic treatment of the intoxicants by MDMA.
Drug Metabolism Letters
Title: The Effects of the 3,4-Methylenedioxymethamphetamine (Ecstasy) in Some Cerebral Areas: Role of the Oxidative Stress
Volume: 2 Issue: 2
Author(s): Sergio Franzese and Anna Capasso
Affiliation:
Abstract: The purpose of the present review is to examine the effect of the acute administration (20 mg/ Kg, i.p.) of the 3,4 methylenedioxymethamphetamine (MDMA) in different cerebral areas of rats to better understand the mechanism underlying the toxicity induced by cellular oxidative stress. For this purpose the biochemical parameters of the antioxidant non-enzymatic cellular defense system have been studied (the reduced Glutathione (GSH), the Glutathione Disulfide (GSSG), the Ascorbic Acid (AA) and malondialdehyde (MDA) which indicates perioxidative damage) in the hippocampus, striate, frontal cortex both in treated animals and in control groups to realize a qualitative-quantitative evaluation of the possible alterations of the neuronal redox state induced by the administration of Ecstasy. The administration of MDMA induced the following variations of the antioxidant non enzymatic defense system: 1. the levels of the AA in the treated animals compared with the control group were increased in the striate, hippocampus and in the frontal cortex both at 3h and 6h. 2. In the striate, also MDA was significantly increased both after 3 h and 6 h, while in the hippocampus and in the frontal cortex the MDA was significantly increased after 6 h. 3. An increase of GSH was also observed after 3 h and 6 h in the hippocampus and in the striate while no significative variation were observed in the frontal cortex of the treated rats. 4. An increase of GSSG was significative in the hippocampus and striate at 3h, while at 6h it was significative only in the striate. In conclusion the results of our study seem to confirm the role of the oxidative stress in the mechanism of neuronal toxicity induced by the ecstasy and leads us to hypothesize a possible role of the antioxidant substances in the therapeutic treatment of the intoxicants by MDMA.
Export Options
About this article
Cite this article as:
Franzese Sergio and Capasso Anna, The Effects of the 3,4-Methylenedioxymethamphetamine (Ecstasy) in Some Cerebral Areas: Role of the Oxidative Stress, Drug Metabolism Letters 2008; 2 (2) . https://dx.doi.org/10.2174/187231208784040924
DOI https://dx.doi.org/10.2174/187231208784040924 |
Print ISSN 1872-3128 |
Publisher Name Bentham Science Publisher |
Online ISSN 1874-0758 |
Related Articles
-
Astrocytes: Implications for Neuroinflammatory Pathogenesis of Alzheimers Disease
Current Alzheimer Research Importance of ABC Transporters in Drug Development
Current Pharmaceutical Design Imidazoles as Potential Antifungal Agents: A Review
Mini-Reviews in Medicinal Chemistry Editorial
Current Drug Therapy Neuronal Self-Repair Following Cerebral Ischemic Insults
Central Nervous System Agents in Medicinal Chemistry Jun Dimerization Protein 2 in Oxygen Restriction; Control of Senescence
Current Pharmaceutical Design Signalling Pathways Activated by Ultraviolet Radiation: Role in Ocular and Cutaneous Health
Current Pharmaceutical Design The Clock Drawing Test: A Reasonable Instrument to Assess Probable Dementia in Primary Care?
Current Alzheimer Research Ghrelin and the Brain-gut Axis as a Pharmacological Target for Appetite Control
Current Pharmaceutical Design Editorial (Thematic Issue: Impact of Early Life Stress on Psychiatric Disorders: Searching New Biomarkers and Innovative Pharmacological Targets)
Current Pharmaceutical Design 1,8-Naphthyridine derivatives as Cholinesterases Inhibitors and Cell Ca2+ Regulators, a Multitarget Strategy for Alzheimer's Disease
Current Topics in Medicinal Chemistry Mitochondrial Biogenesis Inhibitors for Anticancer Therapy: A Review of Recent Patents
Recent Patents on Anti-Cancer Drug Discovery Acute Effects of Oral Tofisopam on Plasma Concentration and Urinary Excretion of Uric Acid and Oxypurinol “Preliminary Communication”
Current Clinical Pharmacology Evidences of Monomer, Dimer and Trimer of Recombinant Human Cyclophilin A
Protein & Peptide Letters Calcium Channel Mutations in Cardiac Arrhythmia Syndromes
Current Molecular Pharmacology Molecular Markers of Tumor Progression in Melanoma
Current Genomics Bupropion in the Depression-Related Sexual Dysfunction: A Systematic Review
CNS & Neurological Disorders - Drug Targets Development of Novel Amyloid Imaging Agents Based Upon Thioflavin S
Current Alzheimer Research Emerging Indications for Statins: A Pluripotent Family of Agents with Several Potential Applications
Current Pharmaceutical Design Chiral Pool/Henry/Enzymatic Routes to Acetogenin Synthons
Letters in Organic Chemistry